| Literature DB >> 16221951 |
S T Engelter1, M Reichhart, L Sekoranja, D Georgiadis, A Baumann, B Weder, F Müller, R Lüthy, M Arnold, P Michel, H P Mattle, B Tettenborn, H J Hungerbühler, R W Baumgartner, R Sztajzel, J Bogousslavsky, P A Lyrer.
Abstract
This databank-based, multicenter study compared all stroke patients with IV tissue plasminogen activator aged > or = 80 years (n = 38) and those < 80 years old (n = 287). Three-month mortality was higher in older patients. Favorable outcome (modified Rankin scale < or = 1) and intracranial hemorrhage (asymptomatic/symptomatic/fatal) were similarly frequent in both groups. Logistic regression showed that stroke severity, time to thrombolysis, glucose level, and history of coronary heart disease independently predicted outcome, whereas age did not.Entities:
Mesh：
Substances：
Year: 2005 PMID： 16221951 DOI： 10.1212/01.wnl.0000183702.04080.27
Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910